Histogen Inc. (HSTO): Price and Financial Metrics

Histogen Inc. (HSTO): $0.21

0.04 (-16.00%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add HSTO to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#122 of 381

in industry

HSTO Price/Volume Stats

Current price $0.21 52-week high $0.93
Prev. close $0.25 52-week low $0.05
Day low $0.21 Volume 1,900
Day high $0.21 Avg. volume 15,001
50-day MA $0.28 Dividend yield N/A
200-day MA $0.39 Market Cap 897.12K

HSTO Stock Price Chart Interactive Chart >


Histogen Inc. (HSTO) Company Bio


Histogen Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California.


HSTO Latest News Stream


Event/Time News Detail
Loading, please wait...

HSTO Latest Social Stream


Loading social stream, please wait...

View Full HSTO Social Stream

Latest HSTO News From Around the Web

Below are the latest news stories about HISTOGEN INC that investors may wish to consider to help them evaluate HSTO as an investment opportunity.

Histogen to Explore Strategic Alternatives

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function, today announced that it has completed a review of its business, including the status of programs, resources and capabilities, and has decided to pause further development of its programs

Yahoo | July 5, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic with traders on Thursday as we go over the shares seeing the biggest movements this morning.

William White on InvestorPlace | June 8, 2023

Histogen Reports First Quarter 2023 Results and Provides Business Update

Received FDA Clearance of IND Application for Emricasan for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Emricasan Treatment has Therapeutic Effect Against Bacterial Skin Infection in Mice Signed Exclusive Intellectual Property License Agreement with Johns Hopkins University Steven J. Mento Ph.D. Appointed President and CEO SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potentia

Yahoo | May 11, 2023

Histogen Announces Online Publication in the Journal of Investigative Dermatology

Emricasan Treatment has Therapeutic Effect Against Bacterial Skin Infection in Mice Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases SAN DIEGO, April 20, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function, today

Yahoo | April 20, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!

William White on InvestorPlace | April 5, 2023

Read More 'HSTO' Stories Here

HSTO Price Returns

1-mo -30.00%
3-mo N/A
6-mo -39.13%
1-year -74.67%
3-year -98.74%
5-year -99.68%
YTD -31.75%
2023 -62.93%
2022 -87.53%
2021 -56.11%
2020 -81.05%
2019 -76.88%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!